We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

135 hedge funds and large institutions have $780M invested in Amicus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 34 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more call options, than puts

Call options by funds: $16.4M | Put options by funds: $6.15M

110.21% more ownership

Funds ownership: 0% → 110.21% (+110%)

62% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 34

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% less funds holding

Funds holding: 136 → 135 (-1)

28% less capital invested

Capital invested by funds: $1.08B → $780M (-$302M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
135
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
3.37%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
28
Increased
55
Reduced
34
Closed
27
Calls
$16.4M
Puts
$6.15M
Net Calls
+$10.3M
Net Calls Change
-$4.71M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$22M
2
Morgan Stanley
Morgan Stanley
New York
+$20.8M
3
Axa
Axa
France
+$15M
4
Jennison Associates
Jennison Associates
New York
+$9.49M
5
JP Morgan Chase
JP Morgan Chase
New York
+$6.69M

Top Sellers

Rank Fund Capital Flow
1
CC
CQS Cayman
Cayman Islands
-$12M
2
EA
Emerald Advisers
Pennsylvania
-$10M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$9.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.98M
5
Invesco
Invesco
Georgia
-$7.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$1.3M +$820K +118,545 +82%
TA
52
Teachers Advisors
New York
$1.2M +$261K +37,705 +19%
CCI
53
Columbus Circle Investors
$1.17M -$661K -95,505 -29%
ECM
54
Endurant Capital Management
California
$1.12M +$1.26M +182,400 +425%
Barclays
55
Barclays
United Kingdom
$1.11M +$598K +86,404 +63%
Swiss National Bank
56
Swiss National Bank
Switzerland
$1.04M +$192K +27,700 +15%
EAM
57
EverPoint Asset Management
Connecticut
$1.04M +$1.46M +210,272 New
CS
58
Credit Suisse
Switzerland
$918K +$270K +38,966 +27%
California Public Employees Retirement System
59
California Public Employees Retirement System
California
$917K – – –
QI
60
QS Investors
New York
$911K – – –
ACP
61
Acuta Capital Partners
California
$722K -$3.63M -524,700 -78%
TD Asset Management
62
TD Asset Management
Ontario, Canada
$713K +$126K +18,200 +15%
Bank of America
63
Bank of America
North Carolina
$709K +$507K +73,238 +105%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$705K – – –
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$650K +$80.6K +11,646 +10%
Millennium Management
66
Millennium Management
New York
$627K +$873K +126,091 New
Wells Fargo
67
Wells Fargo
California
$622K +$405K +58,563 +88%
NFA
68
Nationwide Fund Advisors
Ohio
$588K -$16.2K -2,335 -2%
ProShare Advisors
69
ProShare Advisors
Maryland
$581K +$91.3K +13,193 +13%
Manulife (Manufacturers Life Insurance)
70
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$487K +$70K +10,118 +11%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$484K -$41.6K -6,016 -6%
LCM
72
Laurion Capital Management
New York
$454K +$632K +91,300 New
BG
73
BlackRock Group
United Kingdom
$416K +$68.4K +9,888 +13%
BA
74
BlackRock Advisors
Delaware
$414K -$313K -45,192 -35%
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$370K +$41.5K +6,000 +8%
1 2
3
4 5

FOLD Hedge Fund Activity: Q4 2016 in Review

135 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2016, worth a combined $780M — down 28% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FOLD positions and 27 closed out — a net gain of 1 holder — while 55 added to existing stakes and 34 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $22M. The largest seller was CQS Cayman, exiting entirely with an estimated $12M sold.

  • 135 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2016, down from 136 in Q3 2016.
  • Funds reported $780M of Amicus Therapeutics stock for Q4 2016, down 28% quarter-over-quarter.
  • 28 funds opened new Amicus Therapeutics positions in Q4 2016 and 27 closed out, a net change of +1 holder.
  • The largest Amicus Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $22M added.
  • The largest Amicus Therapeutics seller in Q4 2016 was CQS Cayman, an estimated $12M sold.

Based on aggregated 13F filings for Q4 2016.